11/15/2024
3:32 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form NT 10-Q | |
11/15/2024
3:30 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/11/2024
4:36 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
1:26 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
11:15 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form EFFECT | |
08/27/2024
8:00 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/26/2024
4:18 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
| Form SC 13D/A | |
|
08/23/2024
3:35 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
| Form SC 13D/A | |
08/23/2024
3:36 PM | Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
| Form SC 13D/A | |
08/21/2024
1:24 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
10:59 AM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:01 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:03 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
11:04 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
11:20 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q/A | |
08/19/2024
4:13 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024
3:27 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
4:01 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form NT 10-Q | |
07/22/2024
3:52 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
| Form SC 13D/A | |
07/17/2024
5:20 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:00 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
11:40 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
2:49 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
2:51 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
11:15 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:06 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
SHATTUCK KOHN BARBARA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:10 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Mathis Donald H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:13 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Graff David Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
9:15 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
PFENNIGER RICHARD C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
7:53 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:54 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:55 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:56 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:57 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024
7:45 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
06/18/2024
3:43 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
11:14 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form DEFA14A | |
06/07/2024
10:35 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
4:27 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form DEF 14A | |
05/30/2024
3:45 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/23/2024
4:19 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form PRE 14A | |
My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad) One tiny company...
Could quickly become "the next SpaceX."
It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00.
Get urgent details inside this free report... The Next SpaceX Pre-IPO |
05/20/2024
4:28 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
FROST PHILLIP MD ET AL (Filed by)
| Form SC 13D/A | |
05/16/2024
7:02 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
11:21 AM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
Schulke Ryan (Filed by)
| Form SC 13D/A | |
05/16/2024
11:22 AM | Conlin Matthew (Filed by)
Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
| Form SC 13D/A | |
05/15/2024
8:55 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:30 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Frost Gamma Investments Trust (Reporting)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:50 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024
3:18 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
4:22 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
4:21 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form ARS | |
04/02/2024
3:21 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
4:18 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
5:01 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
4:57 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:16 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:17 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:26 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:43 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:40 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:41 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:43 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:23 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:24 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4/A | |
03/06/2024
5:25 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:25 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
11:05 AM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
4:51 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
JB CAPITAL PARTNERS LP (Filed by)
| Form SC 13G/A | |
02/12/2024
3:54 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form DEF 14A | |
02/08/2024
9:30 AM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
WELLINGTON TRUST Co N A (Filed by)
| Form SC 13G/A | |
02/01/2024
3:50 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form PRE 14A | |
01/19/2024
3:36 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
2:32 PM | Cogent Biosciences (Filer)
Fluent, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:05 PM | Cogent Biosciences (Subject)
Fluent, Inc. (Subject)
GLOBAL VALUE INVESTMENT CORP. (Filed by)
| Form SC 13D/A | |
12/18/2023
4:57 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
4:58 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
9:23 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
9:28 AM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
10:21 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Patrick Donald Huntley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
8:54 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
8:57 AM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
1:50 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:44 AM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:46 AM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Perfit Ryan MacNab (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:13 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:46 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4/A | |
11/30/2023
7:59 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:01 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:32 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:25 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
8:23 PM | Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
Schulke Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump said you could learn something from this man (Ad) Early Warning: A Deep Crack Is Forming In The US Economy
Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.  Here’s everything you need to know. |
11/21/2023
8:28 PM | Conlin Matthew (Reporting)
Cogent Biosciences (Issuer)
Fluent, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
